Both DEMS (2018) and DEMS-Nixus (2019-2021) are built around their proprietary Data Excellence Management System product.
GLOBAL DATA EXCELLENCE SA
Swiss tech SME building enterprise data collaboration platforms; sole beneficiary of two H2020 SME Instrument grants for their DEMS product.
Their core work
Global Data Excellence SA is a Swiss technology SME specializing in enterprise data management and collaborative data-sharing platforms. Their core product — the DEMS (Data Excellence Management System) — is designed to help businesses extract and create value from their data through structured collaboration and sharing frameworks. They successfully progressed through both phases of the EU SME Instrument, moving from a feasibility study to a full commercial development project, which indicates a viable, market-ready technology trajectory. Based in Plan-les-Ouates near Geneva, they operate in the B2B software space with a focus on making data assets more productive for organizations.
What they specialise in
DEMS-Nixus explicitly targets business value creation through fostering collaboration and data sharing between organizations.
Both projects are classified under the SME Innovation pillar, indicating their technology targets SME-scale business operations rather than large enterprise infrastructure.
How they've shifted over time
Their H2020 trajectory follows a textbook SME Instrument progression: a 2018 Phase 1 feasibility project (EUR 50,000) to validate their DEMS concept, followed immediately by a 2019 Phase 2 full-development project (EUR 2,004,450) to bring it to market. This rapid phase-to-phase success suggests the feasibility study produced strong results and the technology was considered commercially compelling by EU evaluators. With no keyword data available across either period, it is not possible to confirm whether the technical focus shifted during this window, but the product naming continuity — DEMS to DEMS-Nixus — suggests evolution of a single platform rather than a pivot.
They appear to be on a commercialization trajectory for a data collaboration platform, having secured Phase 2 EU funding through 2021 — a future partner should investigate whether DEMS-Nixus reached market and what their current product status is.
How they like to work
GDE SA has acted exclusively as coordinator on both of their H2020 projects, and the SME Instrument is typically a single-beneficiary instrument — meaning they have driven both projects independently rather than within a consortium. Their recorded partner count is zero, which is consistent with solo SME instrument applications. This means there is no observable consortium collaboration history; any partner seeking to work with them would be forging an entirely new relationship.
GDE SA has no recorded H2020 consortium partners and no cross-country collaboration history within this dataset. Their EU funding history is entirely self-directed through the solo SME Instrument track, so their external research network — if any — is not visible here.
What sets them apart
GDE SA is one of relatively few Swiss SMEs to have successfully secured both phases of the H2020 SME Instrument for the same product line, which signals strong commercial validation from EU evaluators and a credible path from concept to market. Their focus on data collaboration and value-sharing platforms positions them at the intersection of data governance and business productivity — a space with growing regulatory and commercial relevance in Europe. For a consortium builder, they bring product development credentials and EU grant track record rather than academic research depth.
Highlights from their portfolio
- DEMS-NixusThe largest project in their portfolio at EUR 2,004,450 and a Phase 2 SME Instrument award — the most competitive EU funding track for SMEs — confirming external validation of their data-sharing platform's commercial potential.
- DEMSA successful Phase 1 feasibility project that directly unlocked the Phase 2 award, demonstrating a disciplined product development approach from concept validation to full commercialization.